LONDON, April 19, 2010 /PRNewswire/ -- Healthcare has always been an area of utmost importance. It has significant economic relevance and has been allocated a higher percent of gross domestic product (GDP) in many countries compared to most other sectors such as transport and communication, construction and education. Healthcare also has a huge impact on employment, for the fact that most related activities are provided by people.


New analysis from Frost Sullivan (, Key Trends and Indicators in European Healthcare Markets, studies the healthcare market in Europe and provides insights and analysis up to 2014. For instance, it covers the extent of unemployment in Europe so that healthcare employers can understand the existing market scenario and take advantage of it.

There are a number of political, economic, sociological, and technological market forces which are currently influencing the European healthcare market on the whole, says Frost Sullivan Research Analyst Sree Vidhya Praveen. A combination of these forces produces a few general market opportunities and threats for product manufacturers and it is vital that medical product suppliers have an understanding of these factors to optimise opportunities and address challenges.

The demographic and economic indicators covered in this study focus on the healthcare spending percent of GDP, population analysis and fertility rates. The health status section discusses trends for obesity, alcohol consumption, along with the prevalence of cancer, AIDS and diabetes.

Despite the significant GDP allocation, macroeconomic factors, such as aging populations and insufficient public funding are challenging both payers and providers, explains Praveen. Therefore, participants wanting to succeed in this new market environment should redefine and adapt their business models accordingly.

Governments across the world face the challenge of facilitating the adoption of medical devices while ensuring their affordability. Governments have the responsibility to balance the technological adoption and affordability, thus creating a favourable market environment for medical devices according to the unique features of each country.

Further, policy tools that encourage technological adoption tend to show a strong preference for a particular technology over others. Such tools should be used carefully, say on a trial basis, during the early stages of technological diffusion as the benefits of a new technology are often difficult to predict and can lead to market distortions and a sharp rise in expenditures.

Market participants should increase their product portfolio by acquiring smaller companies with innovative products, concludes Praveen. Additionally, market presence should be expanded in the untapped markets.

If you are interested in more information on Frost Sullivan's Key Trends and Indicators in European Healthcare Markets, please send an e-mail to Katja Feick, Corporate Communications, at, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

Key Trends and Indicators in European Healthcare Markets is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following: An Overview of Medical Device Supply Chain Trends in Europe, An Overview of Ulceration Wounds, European Braces and Supports Market, Western European Market for Image Guided and Robotic Surgery, Surgical Drapes, Gowns and Gloves Market in Europe, The Sterilisation and Disinfection Equipment Market in Eastern Europe, Overview of the Healthcare Industry in Russia and Other CIS Countries, among others. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost Sullivan

Frost Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit

Key Trends and Indicators in European Healthcare Markets M513 Contact: Katja Feick Corporate Communications - Europe P: +49-(0)-69-7703343 E: Twitter:

SOURCE: Frost SOURCE: Sullivan

CONTACT: Katja Feick of Frost Sullivan Corporate Communications -Europe, +49-(0)-69-7703343,